Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12741 | 821 | 45.0 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MKP 1 | Author keyword | 27 | 36% | 7% | 59 |
2 | MAP KINASE PHOSPHATASE | Author keyword | 18 | 53% | 3% | 24 |
3 | DUAL SPECIFICITY PHOSPHATASE | Author keyword | 17 | 42% | 4% | 31 |
4 | PTP INHIBITOR | Author keyword | 16 | 65% | 2% | 15 |
5 | MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1 | Author keyword | 12 | 47% | 2% | 18 |
6 | DUAL SPECIFICITY PHOSPHATASES | Author keyword | 11 | 49% | 2% | 17 |
7 | MKP 2 | Author keyword | 10 | 73% | 1% | 8 |
8 | DUSP | Author keyword | 10 | 61% | 1% | 11 |
9 | DUSP26 | Author keyword | 8 | 100% | 1% | 5 |
10 | CANC UK ST S PONSE | Address | 7 | 57% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MKP 1 | 27 | 36% | 7% | 59 | Search MKP+1 | Search MKP+1 |
2 | MAP KINASE PHOSPHATASE | 18 | 53% | 3% | 24 | Search MAP+KINASE+PHOSPHATASE | Search MAP+KINASE+PHOSPHATASE |
3 | DUAL SPECIFICITY PHOSPHATASE | 17 | 42% | 4% | 31 | Search DUAL+SPECIFICITY+PHOSPHATASE | Search DUAL+SPECIFICITY+PHOSPHATASE |
4 | PTP INHIBITOR | 16 | 65% | 2% | 15 | Search PTP+INHIBITOR | Search PTP+INHIBITOR |
5 | MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1 | 12 | 47% | 2% | 18 | Search MITOGEN+ACTIVATED+PROTEIN+KINASE+PHOSPHATASE+1 | Search MITOGEN+ACTIVATED+PROTEIN+KINASE+PHOSPHATASE+1 |
6 | DUAL SPECIFICITY PHOSPHATASES | 11 | 49% | 2% | 17 | Search DUAL+SPECIFICITY+PHOSPHATASES | Search DUAL+SPECIFICITY+PHOSPHATASES |
7 | MKP 2 | 10 | 73% | 1% | 8 | Search MKP+2 | Search MKP+2 |
8 | DUSP | 10 | 61% | 1% | 11 | Search DUSP | Search DUSP |
9 | DUSP26 | 8 | 100% | 1% | 5 | Search DUSP26 | Search DUSP26 |
10 | MAPK PHOSPHATASE | 7 | 46% | 1% | 11 | Search MAPK+PHOSPHATASE | Search MAPK+PHOSPHATASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DUAL SPECIFICITY PHOSPHATASE | 64 | 37% | 17% | 137 |
2 | MKP 1 | 55 | 65% | 6% | 53 |
3 | CATALYTIC ACTIVATION | 35 | 38% | 9% | 74 |
4 | PROINFLAMMATORY CYTOKINE BIOSYNTHESIS | 27 | 56% | 4% | 33 |
5 | MKP3 | 18 | 83% | 1% | 10 |
6 | MKP 1 EXPRESSION | 18 | 89% | 1% | 8 |
7 | DUAL SPECIFICITY PHOSPHATASES | 17 | 35% | 5% | 39 |
8 | PROTEIN KINASE PHOSPHATASE 1 | 17 | 34% | 5% | 40 |
9 | VHR | 16 | 49% | 3% | 24 |
10 | PROTEIN KINASE PHOSPHATASE | 14 | 65% | 2% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases | 2007 | 375 | 70 | 66% |
Dual-specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling | 2013 | 58 | 132 | 51% |
Dual-specificity phosphatases: critical regulators with diverse cellular targets | 2009 | 248 | 182 | 48% |
Dual-specificity MAP kinase phosphatases (MKPs) and cancer | 2008 | 192 | 67 | 69% |
DUSPs, to MAP kinases and beyond | 2012 | 28 | 91 | 79% |
Mitogen-Activated Protein Kinase Phosphatase 1 as an Inflammatory Factor and Drug Target | 2014 | 6 | 122 | 60% |
Dual-Specificity Phosphatases as Molecular Targets for Inhibition in Human Disease | 2014 | 8 | 200 | 42% |
MAPK phosphatases - regulating the immune response | 2007 | 210 | 109 | 53% |
Structure and regulation of MAPK phosphatases | 2004 | 267 | 77 | 48% |
Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease | 2012 | 27 | 169 | 59% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC UK ST S PONSE | 7 | 57% | 1.0% | 8 |
2 | CR UK ST S PONSE | 4 | 75% | 0.4% | 3 |
3 | NATIONWIDE CHILDRENS HOSP MED PEDIAT | 2 | 67% | 0.2% | 2 |
4 | SECT BIOCHEM ONCOL IMMUNOL | 2 | 67% | 0.2% | 2 |
5 | STRUCT BASED DRUG DESIGN DEV | 2 | 67% | 0.2% | 2 |
6 | PROGRAM MOL BIOL GENETKARMANOS CANC | 2 | 50% | 0.4% | 3 |
7 | BIOCHEM ONCOL IMMUNOL | 2 | 22% | 1.0% | 8 |
8 | ELA KODESZ CANC DEV PREVENT | 2 | 31% | 0.6% | 5 |
9 | HALLETT DIABET ENDOCRINOL | 1 | 21% | 0.7% | 6 |
10 | KARMANOS CANC PROGRAM MOL BIOL HUMAN GENET | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000199337 | KSR1//PEA 15//IST ENDOCRINOL ONCOL SPERIMENTALE GAETANO SALVA |
2 | 0.0000129438 | PTP1B//PROTEIN TYROSINE PHOSPHATASE//PROTEIN TYROSINE PHOSPHATASE 1B |
3 | 0.0000125210 | VRK1//VRK2//EXPT THER EUT TRANSLAT ONCOL PROGRAM |
4 | 0.0000117308 | PRL 3//PHOSPHATASE OF REGENERATING LIVER 3//PRL 1 |
5 | 0.0000114417 | RAF//RAF 1//LEO JENKINS CANC |
6 | 0.0000110731 | JNK//MKK4//JNK3 |
7 | 0.0000095437 | CDC25B//CDC25A//AUTOSCHIZIS |
8 | 0.0000082076 | MK2//MAPKAP K2//MK5 |
9 | 0.0000068289 | CDKN3//CYCLIN DEPENDENT KINASE ASSOCIATED PROTEIN PHOSPHATASE//CYTOKINE EXPRESSION PATTERN |
10 | 0.0000057046 | PPM1D//WIP1//CELL CYCLE CONTROL TUMORIGENESIS GRP |